Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abbott Laboratories (NY: ABT ) 112.73 +0.12 (+0.11%) Official Closing Price Updated: 7:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,508,933 Open 112.31 Bid (Size) 112.62 (1) Ask (Size) 113.75 (1) Prev. Close 112.61 Today's Range 112.10 - 112.93 52wk Range 89.67 - 121.64 Shares Outstanding 1,750,942,289 Dividend Yield 1.81% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Navigating 6 Analyst Ratings For Abbott Laboratories Today 14:00 EDT Via Benzinga 2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off September 25, 2024 These dividend players could lift your portfolio no matter what the market is doing. Via The Motley Fool Performance YTD +2.62% +2.62% 1 Month -0.33% -0.33% 3 Month +7.72% +7.72% 6 Month -0.82% -0.82% 1 Year +18.00% +18.00% More News Read More Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst September 19, 2024 Via Benzinga This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday September 19, 2024 Via Benzinga 20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates September 18, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors. September 11, 2024 Via Chartmill Looking Into Abbott Laboratories's Recent Short Interest August 29, 2024 Via Benzinga Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns September 17, 2024 Via MarketBeat Topics Economy Exposures Economy Interest Rates Can AbbVie Regain Its Status As a Top Dividend Growth Stock? September 16, 2024 Via The Motley Fool Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy? September 16, 2024 Via The Motley Fool 3 Stocks to Buy and Hold Forever September 14, 2024 Via The Motley Fool 3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold September 13, 2024 Via The Motley Fool 2 Stocks That Are Passive Income Machines to Buy and Hold Forever September 11, 2024 Via The Motley Fool Medtronic Stock: Growth On Rise of the Cardiovascular Machines September 09, 2024 Via MarketBeat Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System September 05, 2024 Via Benzinga Topics Product Recall Exposures Legal Product Safety Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device September 05, 2024 Via Investor's Business Daily 3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever August 30, 2024 Via The Motley Fool Patchy But Still Bullish September 02, 2024 Via Talk Markets Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain August 26, 2024 Via Benzinga Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients August 26, 2024 Via Benzinga Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back? August 26, 2024 Via Investor's Business Daily This Is Great News for Medtronic, but Is It Time to Buy the Stock? August 26, 2024 Via The Motley Fool Donald Trump Owns These 21 Dividend Kings. Should You? August 26, 2024 Via The Motley Fool Topics Government Exposures Political 3 Unstoppable Dividend Stocks to Buy Right Now August 25, 2024 Via The Motley Fool Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally August 23, 2024 Via MarketBeat Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.